Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
Más filtros

País/Región como asunto
Intervalo de año de publicación
1.
Beijing Da Xue Xue Bao Yi Xue Ban ; 54(6): 1151-1157, 2022 Dec 18.
Artículo en Zh | MEDLINE | ID: mdl-36533347

RESUMEN

OBJECTIVE: To obtain eripheral blood mesenchymal stem cells (PBMSCs) from sheep and rabbits by continuous mobilization of granulocyte colony-stimulating factor (G-CSF), and by comparing the success rates, cell yields and biological characteristics of the two sources of PBMSCs, and to provide the experimental basis for the preclinical study of PBMSCs transplantation to repair articular cartilage injury and cartilage tissue engineering. METHODS: Through morphological characteristics, flow cytometry analysis of its surface markers, and induction of trilineage differentiation of the two cells in vitro (ie: adipogenic differentiation, osteogenic differentiation, chondrogenic differentiation), the obtained cells were finally confirmed to be PBMSCs. The colony-forming units (CFUs) and the acquisition success rates of the two PBMSCs were counted and compared, and the production of the second generation of the two PBMSCs was counted and compared by hemocytometer, and the cell counting kit-8 was used to detect the doubling time of the two PBMSCs, and the results of trilineage differentiation were quantitatively analyzed by image processing. RESULTS: Microscopically, the PBMSCs of fusiform sheep and rabbits were arranged in fish group, and the second generation of sheep and rabbit PBMSCs expressed CD44 and CD90, but not CD34 and CD45. The induction of trilineage differentiation of the two cells in vitro were successful. The CFUs of primary sheep and rabbits PBMSCs were: 7.27±1.56, 5.73±1.62, and the success rate of acquisition of sheep and rabbits PBMSCs were 78.57% and 36.67%. The number of the second-generation sheep and rabbits PBMSCs that obtained per milliliter of peripheral blood were: 29 582±2 138, 26 732±2 286, and the cell doubling times (h) of the third-generation sheep and rabbits PBMSCs were: 22.32±0.28, 33.21±0.64, the cell doubling time (h) of the fourth generation sheep and rabbits PBMSCs were: 23.62±0.56, 35.30±0.38, and the quantitative lipid ratio of sheep and rabbit PBMSCs were: 7.77%±3.81%, 17.05%±1.52%, sheep and rabbit PBMSCs chondroglobus acid mucopolysaccharide positive ratios were: 11.67%±0.53%, 8.14%±0.57%. There were statistical differences among the above groups (P < 0.05). CONCLUSION: The continuous mobilization of G-CSF to obtain sheep PBMSCs is more efficient. Sheep PBMSCs have more abundant yield and stronger proliferation ability.Sheep PBMSCs can produce more acidic mucopolysaccharides and have lower adipogenic abi-lity under appropriate conditions. Sheep PBMSCs have good research prospects in repair of articular cartilage injury with autologous stem cell transplantation and preclinical animal in vivo experiment of cartilage tissue engineering.This experiment provides further experimental basis for this kind of research.


Asunto(s)
Cartílago Articular , Trasplante de Células Madre Hematopoyéticas , Células Madre Mesenquimatosas , Ovinos , Conejos , Animales , Osteogénesis , Células Cultivadas , Trasplante Autólogo , Diferenciación Celular , Cartílago Articular/lesiones , Factor Estimulante de Colonias de Granulocitos
2.
Beijing Da Xue Xue Bao Yi Xue Ban ; 52(3): 527-534, 2020 Jun 18.
Artículo en Zh | MEDLINE | ID: mdl-32541988

RESUMEN

OBJECTIVE: To estimate the prevalence rate of bone and joint injury in China and to describe the three-dimension distribution of the disease (area, time and people). METHODS: Based on a cross-sectional design, a retrospective study was conducted by using Chinese basic medical insurance database from January 1, 2013 to December 31, 2017 to analyze the epidemiological characteristics of bone and joint injury. The prevalence rate of bone and joint injury in each city was calculated, and then using meta-analyses to estimate the pooled prevalence of each area and the whole country. The pooled prevalence rates were compared among the different groups of populations, in terms of geographical area, time and population characteristics (age and gender). RESULTS: A total of 28 419 264 subjects were included in this study, including 705 793 patients with bone and joint injury. From 2013 to 2017, in Chinese basic medical insurance database, the overall prevalence rate of bone and joint injury was 141.5(95%CI: 90.4-203.7) per 10 000 population, and the prevalence rates of non-specific or polyarticular disease, knee disease, and shoulder disease were 101.6 (95%CI: 63.5-148.4)per 10 000 population, 22.5(95%CI:15.1-31.4)per 10 000 population and 10.9 (95%CI: 6.4-16.4)per 10 000 population. The prevalence rates varied across the areas, the highest rate was observed in North China, with the prevalence of 310.6 (95%CI: 12.6-989.7) per 10 000 population, and the lowest rate was observed in Southwest China, with the prevalence of 59.0 (95%CI: 37.5-85.2) per 10 000 population. The prevalence rate of bone and joint injury increased over the study period, from 111.1 (95%CI: 56.0-182.5)per 10 000 population in 2013 to 175.5 (95%CI: 116.8-245.5)per 10 000 population in 2017. The prevalence of bone and joint injury in the female population was 149.1 (95%CI: 94.2-215.9) per 10 000 population, which was higher than that of men [133.6(95%CI: 86.2-190.9) per 10 000 population]. The higher prevalence of knee disease, unspecified or polyarticular disease, and bone and joint injury were observed in people aged 60 years and older, while the prevalence of shoulder disease peaked in 40-59 years old people [20.6 (95%CI: 12.5-30.5) per 10 000 population]. CONCLUSION: This study reported a relative low prevalence of bone and joint injury in China from 2013 to 2017. The prevalence increased over the study period, and the highest prevalence rate was observed in North China. The prevalence rate showed differences among different groups of populations, and higher rates were observed in females and people aged 60 years and older.


Asunto(s)
Seguro de Salud , Adulto , China , Bases de Datos Factuales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Población Urbana
3.
Genet Mol Res ; 15(2)2016 May 06.
Artículo en Inglés | MEDLINE | ID: mdl-27173325

RESUMEN

The aim of this study was to detect the expression of transforming growth factor-ß1 (TGF-ß1) in neonatal rats with hyperoxia-induced bronchopulmonary dysplasia (BPD) and to explore its relationship with lung development. Forty-eight rats (2-3 days old) were randomly divided into a hyperoxia group and a control group (N = 24) which were then fed in ≥95% oxygen atmosphere and air, respectively. On the 1st, 3rd and 7th days of hyperoxia exposure, morphological changes of lung tissues were observed under an optical microscope. TGF-ß1 mRNA and protein levels in lung tissues were detected by real-time quantitative polymerase chain reaction and western blot, respectively. With increasing time of hyperoxia exposure, the hyperoxia group gradually suffered from pathological changes such as poor development of lung tissues, alveolar simplification, decrease in the number of alveoli, and hindered pulmonary microvascular development. On the 7th day of hyperoxia exposure, TGF-ß1 mRNA and protein levels (relative to b-actin) of the hyperoxia group (0.34 ± 0.19 and 0.21 ± 0.09, respectively) were significantly lower than those of the control group (0.83 ± 0.45 and 0.57 ± 0.45, respectively; P < 0.05). TGF-ß1 participates in the pathogenesis of BPD as an important regulatory factor during pulmonary vascular development.


Asunto(s)
Displasia Broncopulmonar/metabolismo , Hiperoxia/complicaciones , Pulmón/crecimiento & desarrollo , Factor de Crecimiento Transformador beta1/metabolismo , Animales , Displasia Broncopulmonar/etiología , Displasia Broncopulmonar/genética , Displasia Broncopulmonar/patología , Femenino , Pulmón/metabolismo , Masculino , Ratas , Ratas Sprague-Dawley , Factor de Crecimiento Transformador beta1/genética
4.
Clin Exp Obstet Gynecol ; 41(1): 72-4, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24707688

RESUMEN

OBJECTIVES: This work aims to detect the peritoneal fluid proteomic patterns in endometriosis patients, build diagnostic models, and evaluate its clinical significance. STUDY DESIGN: The authors used SELDI-TOF-MS protein chip array technology to detect biomarkers of peritoneal fluid in endometriosis patients. Fourteen endometriosis patients and 16 persons without endometriosis as control group were tested. RESULTS: Four potential biomarkers (4428m/z, 6891m/z, 13766m/z, and 6427m/z) were found. CONCLUSIONS: This method showed great potential in screening better biomarkers for endometriosis.


Asunto(s)
Líquido Ascítico/química , Biomarcadores/análisis , Endometriosis/diagnóstico , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Adulto , Endometriosis/metabolismo , Femenino , Humanos , Análisis por Matrices de Proteínas/métodos , Adulto Joven
5.
Epidemiol Infect ; 141(2): 334-40, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22578630

RESUMEN

Hypermucoviscous (HV) isolates of Klebsiella pneumoniae have been linked to virulence potential in experimental infections. We examined 33 isolates of K. pneumoniae from patients with bacteraemia for the HV phenotype on agar culture, and determined their virulence potential by screening for capsular (K) serotype by polymerase chain reaction and the presence of seven virulence factor genes. Fourteen (42·4%) isolates expressed the HV phenotype and 11 of these were serotype K1 or K2; these serotypes were not identified in HV-negative isolates. The genes rmpA, rmpA2, aerobactin, wabG and allS were significantly more frequent in HV than non-HV isolates. Multilocus sequence typing identified 21 sequence types (ST), eight of which were found in HV-positive isolates and the clonal relatedness of isolates of the most frequent types (ST23 and ST11) from different hospitals was confirmed by pulsed-field gel electrophoresis. The HV phenotype was more associated with community-acquired infection with a lower frequency of fatal underlying illness, but with significantly more focal infections, notably liver abscesses. Clinicians should be aware of such clinical impacts of the HV phenotype.


Asunto(s)
Antiinfecciosos/farmacología , Bacteriemia/genética , Farmacorresistencia Microbiana/genética , Infecciones por Klebsiella/genética , Klebsiella pneumoniae , Fenotipo , Factores de Virulencia/genética , Bacteriemia/microbiología , Infección Hospitalaria/etiología , Electroforesis en Gel de Campo Pulsado , Humanos , Infecciones por Klebsiella/microbiología , Klebsiella pneumoniae/clasificación , Klebsiella pneumoniae/genética , Klebsiella pneumoniae/patogenicidad , Absceso Hepático/etiología , Tipificación de Secuencias Multilocus/métodos , Reacción en Cadena de la Polimerasa , República de Corea , Estudios Retrospectivos , Serotipificación/métodos , Centros de Atención Terciaria
6.
RSC Adv ; 9(60): 34677-34690, 2019 Oct 28.
Artículo en Inglés | MEDLINE | ID: mdl-35530679

RESUMEN

The morphology and size of primary Si has a significant influence on the thermal conductivity (TC) and strength of Al-17Si-3.5Cu. In this study, the effect of a 1-3 wt% SiC nanoparticle (SiCnps) addition on TC and tensile strength of Al-17Si-3.5Cu was investigated. Nanoparticles distributed at the interface between primary Si and Al led to a significant refinement of primary Si; for example, a primary Si size of 2 µm with 3 wt% SiCnps addition was achieved. TC of SiCnps/Al-17Si-3.5Cu improved with an increase in nanoparticle content. Nanoparticles distributed at the interface between Si and Al reduced the interfacial thermal resistance. Thus, the effective TC of eutectic Si increased. Owing to the refinement of the primary Si and the increased interfacial thermal resistance, originating from the high content of SiCnps at the interface, the effective TC of primary Si decreased. Compared with Al-17Si-3.5Cu, contribution to the improvement of the TC of SiCnps/Al-17Si-3.5Cu resulted mainly from eutectic Si. Due to the refinement of primary Si, the tensile strength of SiCnps/Al-17Si-3.5Cu improved with an increase in SiCnps content. When the SiCnps content was 3 wt%, the yield strength, ultimate tensile strength and elongation of SiCnps/Al-17Si-3.5Cu were ∼176 MPa, 418 MPa and 7%, respectively, which were improved by 37.5%, 53.7% and 218%, respectively, when compared with Al-17Si-3.5Cu.

7.
Int J Tuberc Lung Dis ; 12(6): 692-4, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18492340

RESUMEN

A retrospective review was conducted of patients starting antiretroviral treatment (ART) at Mzuzu Central Hospital, Malawi, to identify those who developed tuberculosis (TB) within 6 months of commencing ART and document their treatment outcomes. Of 2933 patients, 22 (0.75%) developed active TB, 17 (77%) of whom had commenced ART as a result of unexplained weight loss and/or fever. Of those who developed TB, 41% successfully completed anti-tuberculosis treatment, with lower survival probabilities than patients who did not develop TB. Easier methods are needed to diagnose TB in human immunodeficiency virus-infected patients and to prevent patients from developing TB while on ART.


Asunto(s)
Infecciones por VIH/epidemiología , Tuberculosis Pulmonar/epidemiología , Antirretrovirales/uso terapéutico , Antituberculosos/uso terapéutico , Niño , Comorbilidad , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/mortalidad , Humanos , Isoniazida/uso terapéutico , Malaui , Estudios Retrospectivos , Resultado del Tratamiento , Tuberculosis Pulmonar/mortalidad
8.
Eur J Gynaecol Oncol ; 29(3): 233-8, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18592785

RESUMEN

OBJECTIVE: Identification of proteomic alterations in epithelial ovarian tumorigenesis may facilitate the understanding of progression of this disease. METHODS: Specific protein peak patterns were identified in 20 microdissected epithelial ovarian tumors (13 epithelial ovarian cancers (EOCs) and 7 low malignant potential (LMP) tumors), as well as in the matched normal cells. Protein profiles were generated by surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) from all the different types of cells. RESULTS: Among seven protein peaks from EOC cells, six were significantly increased while one was decreased compared with normal cells, and three peaks from LMP cells were markedly increased while one was decreased compared with normal cells. CONCLUSIONS: The combination of SELDI and laser capture microdissection (LCM) is effective in finding the key molecules in ovarian tumorigenesis. Further identification of these protein peaks is important and these malignant protein signatures lend themselves to identification of populations at high-risk for EOC and for monitoring response to EOC chemopreventive agents.


Asunto(s)
Neoplasias Ováricas/metabolismo , Análisis por Matrices de Proteínas/métodos , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/métodos , Epitelio/metabolismo , Femenino , Humanos , Microdisección , Neoplasias Ováricas/patología , Ovario/química , Ovario/patología , Proteómica
9.
Int J Tuberc Lung Dis ; 11(5): 534-8, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17439677

RESUMEN

SETTING: Mzuzu Central Hospital, in the northern region of Malawi, which provides free antiretroviral therapy (ART) to human immunodeficiency virus (HIV) infected adults and children, including those with tuberculosis (TB). OBJECTIVES: To compare outcomes in HIV-infected children who have been started on ART because of 1) active TB, 2) a past history of TB in the last 2 years and 3) a non-TB diagnosis. DESIGN: Retrospective data collection using ART patient master cards and ART patient registers. RESULTS: Between July 2004 and September 2006, 439 (11%) children of a total 3908 patients were started on ART. There were 29 with active TB, 56 with a past history of TB in the last 2 years and 354 with a non-TB diagnosis. The three groups were similar in nutritional indices and CD4-lymphocyte percentages. The 6-month probability of survival was 0.86 in the active TB group, 0.94 in the past history of TB group and 0.89 in the non-TB group. 12-month survival probability for the same groups was 0.86, 0.86 and 0.88, respectively. CONCLUSION: HIV-infected children with active and previous TB who are started on ART have good outcomes that are similar to those of children started on ART due to a non-TB diagnosis.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Infecciones por VIH/complicaciones , Infecciones por VIH/tratamiento farmacológico , Tuberculosis/complicaciones , Adolescente , Antituberculosos/uso terapéutico , Niño , Preescolar , Femenino , Estudios de Seguimiento , Infecciones por VIH/mortalidad , Humanos , Lactante , Malaui , Masculino , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento , Tuberculosis/tratamiento farmacológico
10.
Int J Tuberc Lung Dis ; 11(4): 412-6, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17394687

RESUMEN

SETTING: Public sector facilities in Malawi providing antiretroviral therapy (ART) to human immunodeficiency virus (HIV) positive patients, including those with tuberculosis (TB). OBJECTIVES: To compare 6-month and 12-month cohort treatment outcomes of HIV-positive TB patients and HIV-positive non-TB patients treated with ART. DESIGN: Retrospective data collection using ART patient master cards and ART patient registers. RESULTS: Between July and September 2005, 7905 patients started ART, 6967 with a non-TB diagnosis and 938 with a diagnosis of active TB. 6-month cohort outcomes of non-TB and TB patients censored on 31 March 2006 showed significantly more TB patients alive and on ART (77%) compared with non-TB patients (71%) (P < 0.001). Between January and March 2005, 4580 patients started ART, 4179 with a non-TB diagnosis and 401 with a diagnosis of active TB. 12-month cohort outcomes of non-TB and TB patients censored on 31 March 2006 showed significantly more TB patients alive and on ART (74%) compared with non-TB patients (66%) (P < 0.001). Other outcomes of default and transfer out were also significantly less frequent in TB compared with non-TB patients. CONCLUSION: HIV-positive TB patients on ART in Malawi have generally good treatment outcomes, and more patients need to access this HIV treatment.


Asunto(s)
Antirretrovirales/uso terapéutico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/epidemiología , Tuberculosis/epidemiología , Comorbilidad , Humanos , Malaui/epidemiología , Resultado del Tratamiento
11.
Mol Cell Biol ; 3(7): 1246-54, 1983 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-6310369

RESUMEN

A series of plasmids was constructed to study the effect of two enhancers, the simian virus 40 72-base-pair repeat and the Harvey sarcoma virus 73-base-pair repeat, on the mouse beta maj-globin promoter. These plasmids contain the mouse beta maj-globin promoter linked to the Escherichia coli galK gene, thus allowing galactokinase enzyme activity to be used as a measure of promoter function. In CV-1 (primate) cells, it was found that an enhancer is required for optimal promoter activity and that the simian virus 40 (primate) enhancer increases galactokinase fourfold more than the Harvey sarcoma virus (mouse) enhancer. In L (mouse) cells, however, the Harvey sarcoma virus enhancer is 1.3-fold stronger than the simian virus 40 enhancer. These data support the hypothesis that enhancer activity can be species specific. Furthermore, when both enhancers are present on the same plasmid, their effect is additive on the beta-globin promoter whether the plasmid is in CV-1 cells or L cells.


Asunto(s)
Globinas/genética , Operón , Animales , Células Cultivadas , Mapeo Cromosómico , ADN Viral/genética , Galactoquinasa/genética , Genes Virales , Haplorrinos , Ratones , Plásmidos , Secuencias Repetitivas de Ácidos Nucleicos , Virus del Sarcoma Murino/genética , Virus 40 de los Simios/genética , Transformación Genética
13.
Public Health Action ; 7(2): 83-89, 2017 Jun 21.
Artículo en Inglés | MEDLINE | ID: mdl-28695079

RESUMEN

Setting: Mzuzu Central Hospital (MZCH), Mzuzu, and Chitipa District Hospital (CDH), Chitipa, Malawi. Objective: To compare management and outcomes of human immunodeficiency virus (HIV) exposed infants in early infant diagnosis (EID) programmes at MZCH, where DNA polymerase chain reaction (PCR) testing is performed on site, and CDH, where samples are sent to MZCH, between 2013 and 2014. Design: Retrospective cohort study. Results: Of infants enrolled at MZCH (n = 409) and CDH (n = 176), DNA PCR results were communicated to the children's guardians in respectively 56% and 51% of cases. The median time from sample collection to guardians receiving results was 34 days for MZCH and 56 days for CDH. In both hospitals, only half of the dried blood spot (DBS) samples were collected between 6 and 8 weeks. More guardians from MZCH than CDH received test results within 1 month of sample collection (25% vs. 10%). Among the HIV-positive infants, a higher proportion at MZCH (92%) started antiretroviral therapy than at CDH (46%). The relative risk (RR) of death was higher among infants with late DBS collection (RR 1.3, 95%CI 1.0-1.7) or no collection (RR 5.8, 95%CI 4.6-7.2), and when guardians did not receive test results (RR 8.3, 95%CI 5.7-11.9). Conclusion: EID programmes performed equally poorly at both hospitals, and might be helped by point-of-care DNA PCR testing. Better programme implementation and active follow-up might improve infant outcome and retention in care.


Contexte: Hôpital central Mzuzu (MZCH), Mzuzu, et hôpital de district de Chitipa (CDH), Chitipa, Malawi.Objectif: Comparer la prise en charge et les résultats des nourrissons exposés au virus de l'immunodéficience humaine (VIH) dans les programmes de Diagnostic précoce du nourrisson (EID) au MZCH (test ADN réaction polymérase en chaîne [PCR] fait sur place) et au CDH (échantillons envoyés au MZCH) entre 2013 et 2014.Schéma: Etude rétrospective de cohorteRésultats: Parmi les nourrissons enrôlés au MZCH (n = 409) et au CDH (n = 176), les résultats d'ADN PCR ont été communiqués aux responsables des enfants dans 56% et 51% des cas, respectivement. Le délai médian du recueil de l'échantillon à la réception des résultats par les parents a été de 34 jours pour le MZCH et de 56 jours pour le CDH. Dans les deux hôpitaux, seulement la moitié des échantillons de sang séché (DBS) a été recueillie entre 6 et 8 semaines. Plus de parents du MZCH que du CDH ont reçu les résultats du test dans le mois suivant le recueil de l'échantillon (25% contre 10%). Parmi les nourrissons VIH positifs, une proportion plus élevée au MZCH (92%) a mis en route le traitement antirétroviral comparée au CDH (46%). Le risque relatif de décès a été plus élevé parmi les nourrissons ayant eu un recueil tardif de DBS (RR 1,3 ; IC95% 1,0­1,7) ou pas de recueil (RR 5,8 ; IC95% 4,6­7,2) et quand les parents n'ont pas reçu les résultats du test (RR 8,3 ; IC95% 5,7­11,9).Conclusion: Les programmes d'EID ont été aussi peu performants dans les deux hôpitaux et pourraient être améliorés par la possibilité de réaliser sur place le test PCR ADN. Une meilleure mise en œuvre du programme et un suivi actif pourraient améliorer les résultats pour les nourrissons et leur rétention en soins.


Marco de referencia: El Hospital Central de Mzuzu (MZCH) y el Hospital Distrital de Chitipa (CDH), en Malawi.Objetivo: Comparar el manejo y los desenlaces clínicos de los lactantes expuestos al virus de la inmunodeficiencia humana (VIH) en los programas de diagnóstico temprano del lactante (EID) en el MZCH (realización local de pruebas mediante la reacción en cadena de la polimerasa a partir de ADN [PCR-ADN]) y el CDH (muestras enviadas al MZCH) del 2013 al 2014.Método: Fue este un estudio retrospectivo de cohortes.Resultados: De los lactantes inscritos en el MZCH (n = 409), el resultado de la prueba PCR-ADN se comunicó a la persona encargada del niño en un 56% de los casos; esta proporción fue 51% en los lactantes inscritos en el CDH (n = 176). La mediana del lapso entre la obtención de la muestra y la entrega de los resultados a los encargados fue 34 días en el MZCH y 56 días en el CDH. En ambos hospitales, solo la mitad de las muestras de sangre seca (DBS) se recogió en 6 a 8 semanas. Más tutores de los lactantes en el MZCH que en el CDH recibieron el resultado de la prueba en el primer mes después de haber aportado la muestra (25% contra 10%). De los lactantes con resultado positivo frente al VIH, inició tratamiento antirretrovírico una mayor proporción de los niños atendidos en el MZCH (92%) que en el CDH (46%). El riesgo relativo (RR) de mortalidad fue más alto en los lactantes en quienes se obtuvo la muestra de DBS tardíamente (RR 1,3; IC95% de 1,0 a 1,7), en quienes no se obtuvo (RR 5,8; IC95% de 4,6 a 7,2) y cuando los tutores no recibieron los resultados (RR 8,3; IC95% de 5,7 a 11,9).Conclusión: El desempeño de los programas EID fue igualmente deficiente en ambos hospitales y se podría mejorar con la práctica de la prueba PCR-ADN en el momento de la atención. Una mejor ejecución del programa y un seguimiento activo contribuiría a obtener desenlaces clínicos más favorables en los lactantes y a retenerlos en los servicios de atención.

14.
Theor Appl Genet ; 105(8): 1124-1136, 2002 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-12582890

RESUMEN

Several independent molecular genetic linkage maps of varying density and completeness have been constructed for cultivated sunflower ( Helianthus annuus L.). Because of the dearth of sequence and probe-specific DNA markers in the public domain, the various genetic maps of sunflower have not been integrated and a single reference map has not emerged. Moreover, comparisons between maps have been confounded by multiple linkage group nomenclatures and the lack of common DNA markers. The goal of the present research was to construct a dense molecular genetic linkage map for sunflower using simple sequence repeat (SSR) markers. First, 879 SSR markers were developed by identifying 1,093 unique SSR sequences in the DNA sequences of 2,033 clones isolated from genomic DNA libraries enriched for (AC)(n) or (AG)(n) and screening 1,000 SSR primer pairs; 579 of the newly developed SSR markers (65.9% of the total) were polymorphic among four elite inbred lines (RHA280, RHA801, PHA and PHB). The genetic map was constructed using 94 RHA280 x RHA801 F(7) recombinant inbred lines (RILs) and 408 polymorphic SSR markers (462 SSR marker loci segregated in the mapping population). Of the latter, 459 coalesced into 17 linkage groups presumably corresponding to the 17 chromosomes in the haploid sunflower genome ( x = 17). The map was 1,368.3-cM long and had a mean density of 3.1 cM per locus. The SSR markers described herein supply a critical mass of DNA markers for constructing genetic maps of sunflower and create the basis for unifying and cross-referencing the multitude of genetic maps developed for wild and cultivated sunflowers.

15.
Mar Biotechnol (NY) ; 2(6): 558-70, 2000 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14961179

RESUMEN

The nearly complete nuclear large subunit ribosomal RNA (LSU rRNA) gene in corals was amplified by primers designed from polymerase chain reaction (PCR) strategies. The motif of the putative 3'-terminus of the LSU rRNA gene was sequenced and identified from intergenic spacer (IGS) clones obtained by PCR using universal primers designed for corals. The 3'-end primer was constructed in tandem with the universal 5'-end primer for the LSU rRNA gene. PCR fragments of 3500 bp were amplified for octocorals and non- Acropora scleractinian corals. More than 80% of the Acropora LSU rRNA gene (3000 bp) was successfully amplified by modification of the 5'-end of the IGS primer. Analysis of the 5'-end of LSU rDNA sequences, including the D1 and D2 divergent domains, indicates that the evolutionary rate of the LSU rDNA differs among these taxonomic groups of corals. The genus Acropora showed the highest divergence pattern in the LSU rRNA gene, and the presence of a long branch of the Acropora clade from the other scleractinian corals in the phylogenetic tree indicates that the evolutionary rate of Acropora LSU rDNA might have accelerated after divergence from the common ancestor of scleractinian corals.

16.
J Am Vet Med Assoc ; 218(7): 1101-5, 2001 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-11318359

RESUMEN

OBJECTIVE: To compare hydromorphone with oxymorphone, with or without acepromazine, for preanesthetic sedation in dogs and assess changes in plasma concentration of histamine after drug administration. DESIGN: Randomized clinical study. ANIMALS: 10 healthy mixed-breed dogs. PROCEDURE: Dogs were treated IM with hydromorphone (group H), oxymorphone (group O), hydromorphone with acepromazine (group H/A), or oxymorphone with acepromazine (group O/A). Sedation score, heart rate, respiratory rate, systolic blood pressure, and oxygen saturation were recorded at baseline immediately after drug administration (T0) and every 5 minutes for 25 minutes (T25). Plasma histamine concentration was measured at baseline and T25. RESULTS: Sedation was similar between groups H and 0 at all times. Sedation was significantly greater for groups H/A and O/A from T10 to T25, compared with other groups. Systolic blood pressure was significantly reduced at T25 in group H/A, compared with group H, and in group O/A, compared with group O. Prevalence of panting at T25 was 50% for groups H and O, compared with 20% for group H/A and 30% for group O/A. By T25, heart rate was significantly lower in all groups. Oxygen saturation was unaffected by treatment. Mean +/- SD plasma histamine concentration was 1.72 +/- 2.69 ng/ml at baseline and 1.13 +/- 1.18 ng/ml at T25. There was no significant change in plasma histamine concentration in any group. CONCLUSIONS AND CLINICAL RELEVANCE: Hydromorphone is comparable to oxymorphone for preanesthetic sedation in dogs. Sedation is enhanced by acepromazine. Neither hydromorphone nor oxymorphone caused an increase in plasma histamine concentration.


Asunto(s)
Analgésicos Opioides/farmacología , Perros/fisiología , Liberación de Histamina/efectos de los fármacos , Hidromorfona/farmacología , Oximorfona/farmacología , Acepromazina/farmacología , Animales , Presión Sanguínea/efectos de los fármacos , Antagonistas de Dopamina/farmacología , Combinación de Medicamentos , Frecuencia Cardíaca/efectos de los fármacos , Histamina/sangre , Inyecciones Intramusculares/veterinaria , Masculino
17.
Yi Chuan Xue Bao ; 28(12): 1085-92, 2001.
Artículo en Zh | MEDLINE | ID: mdl-11797336

RESUMEN

The genetic data of MICA microsatellite were obtained by genotyping 577 samples in 13 population groups of China, which are Han-YN, Han-GD, Han-SD, Bai, Dai, Lahu, Li, Naxi, Sala, She, Tu, Wa and Zang-YN, with genescan. Five alleles have been observed in the population groups, which are A4, A5, A5.1, A6 and A9. A5 allele is the most frequent in all population groups except Lahu and Li, while the most frequent allele for Lahu and Li is A5. 1 and A4 respectively. The second most frequent allele is the A5.1 in Han-YN, Han-SD, Dai, Naxi, Sala, She, and Wa. The lest frequent allele for Han-YN, Han-GD, Lahu, Naxi, She, Wa is the A6 which is not observed in Li. A4 allele is the lest frequent in Han-SD, Bai, Dai, Sala, Tu, Zang-YN. The results show that the distribution of MICA microsatellite is different in these population groups, and the polymorphism information contents (PIC) of this microsatellite is high. It is a potential useful marker in the study of human origin and migration, personal identification, gene mapping and location, and disease diagnosis.


Asunto(s)
Antígenos de Histocompatibilidad Clase I/genética , Repeticiones de Microsatélite , China/etnología , Humanos
18.
Yi Chuan Xue Bao ; 28(8): 699-706, 2001 Aug.
Artículo en Zh | MEDLINE | ID: mdl-11554343

RESUMEN

30 autosomal STRs of 6 Chinese populations (Bai, Naxi, Tu, Sala, Han in Shandong, She) were amplified by multiplex PCRs using fluerescein-labelled primers. Shriver's Dsw was estimated on the basis of the results of the genescanning and genotyping after running unnatural PAGE of the PCRs' products on ABI 377 sequencer. Phylogenetic trees were constructed by using Neighbor-Joining and UPGMA method based on Dsw, and then the genetic relationships among them were analyzed referring to some relative informations. Our results indicated that the genetic distance between Sala and Tu is near, 0.033. But the distances between Sala and other four populations are far, over 0.12; Tu is close to Naxi and Shandong Han, and the distances are 0.038, 0.063 respectively; The distance between Bai and Han is the nearest, 0.007, but there is a distance, 0.075, between Bai and Naxi, and a far distance, 0.112, between Bai and Tu; The distance between Naxi and Han is 0.100 and the distances between She and other 5 populations are all over 0.12. In both of the NJ and UPGMA phylogenetic trees, Naxi, Tu and Sala is one cluster and Bai and Han is another cluster. She is a single branch. These results, basically consistent with 6 Chinese populations' geographic distribution and histories, can provide some genetic information to comprehensively study their origin, migration, formation and development with their historical records and archaeological evidence.


Asunto(s)
Pueblo Asiatico/genética , Secuencias Repetidas en Tándem , China/etnología , Humanos , Filogenia
19.
Zhonghua Wai Ke Za Zhi ; 31(8): 456-9, 1993 Aug.
Artículo en Zh | MEDLINE | ID: mdl-8112168

RESUMEN

Using 45 rabbits, the authors made a research on the relationship between the experimental change of the stress-strain distribution and the tissues structural abnormalities of the cervical column. After having changed the stress and strain distribution on the rabbits' cervical vertebrae by letting them bow their heads, we measured the strain distribution in Vivo with resistant strain gauges, inspected the pathological changes of the cervical vertebrae, the nuchal ligaments, the capsular ligaments, the neck muscles and the attachments of the capsular ligament to bones, by ligh microscope and electron microscope. We found that the greater the level of the strain and the longer time the strain was loaded, the more evident the morphological abnormalities of the cervical vertebrae. The increase of the stress and strain could also cause degeneration of the nuchal ligaments, capsular ligaments and neck muscles. We believe that the abnormalities of the of the soft tissues around the cervical vertebral bones play an important part in the development of the cervical spondylosis. We think that the morphological changes of the cervical column is the basis of the biomechanical pathogenesis of the cervical spondylosis.


Asunto(s)
Vértebras Cervicales , Osteofitosis Vertebral/etiología , Animales , Ligamentos , Músculos del Cuello , Conejos , Osteofitosis Vertebral/patología , Estrés Mecánico , Resistencia a la Tracción
20.
Braz J Med Biol Res ; 47(1): 24-34, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24345874

RESUMEN

Fanconi anemia complementation group F protein (FANCF) is a key factor, which maintains the function of FA/BRCA, a DNA damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. We performed a specific FANCF-shRNA knockdown of endogenous FANCF in vitro. Cell viability was measured with a CCK-8 assay. DNA damage was assessed with an alkaline comet assay. Apoptosis, cell cycle, and drug accumulation were measured by flow cytometry. The expression levels of protein were determined by Western blot using specific antibodies. Based on these results, we used cell migration and invasion assays to demonstrate a crucial role for FANCF in those processes. FANCF shRNA effectively inhibited expression of FANCF. We found that proliferation of FANCF knockdown breast cancer cells (MCF-7 and MDA-MB-435S) was significantly inhibited, with cell cycle arrest in the S phase, induction of apoptosis, and DNA fragmentation. Inhibition of FANCF also resulted in decreased cell migration and invasion. In addition, FANCF knockdown enhanced sensitivity to doxorubicin in breast cancer cells. These results suggest that FANCF may be a potential target for molecular, therapeutic intervention in breast cancer.


Asunto(s)
Antineoplásicos/farmacología , Movimiento Celular/genética , Proliferación Celular/genética , Proteína del Grupo de Complementación D2 de la Anemia de Fanconi/genética , Proteína del Grupo de Complementación F de la Anemia de Fanconi/genética , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Resistencia a Medicamentos , Ensayos de Selección de Medicamentos Antitumorales , Regulación Neoplásica de la Expresión Génica , Técnicas de Silenciamiento del Gen , Humanos , Interferencia de ARN , ARN Interferente Pequeño
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA